Covestor’s Ginkgo Bioworks DNA Stock Holding History

Covestor’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	1	–	–	﹤0.01%	2549
2026 Q1	$0	Hold	1	–	–	﹤0.01%	2363
2025 Q4	$0	Hold	1	–	–	﹤0.01%	2351
2025 Q3	$0	Hold	1	–	–	﹤0.01%	2372
2025 Q2	$0	Hold	1	–	–	﹤0.01%	2314
2025 Q1	$0	Hold	1	–	–	﹤0.01%	2326
2024 Q4	$0	Hold	1	–	–	﹤0.01%	2327
2024 Q3	$0	Sell	1 -1	-50%	-$10	﹤0.01%	2315
2024 Q2	$0	Sell	2 -3	-60%	-$90	﹤0.01%	2329
2024 Q1	$0	Buy	5 +1	+25%	+$52	﹤0.01%	2327
2023 Q4	$0	Hold	4	–	–	﹤0.01%	2240
2023 Q3	$0	Sell	4 -2	-33%	-$160	﹤0.01%	2217
2023 Q2	$0	Buy	6 +3	+100%	+$178	﹤0.01%	2226
2023 Q1	$0	Hold	3	–	–	﹤0.01%	2127
2022 Q4	$0	Buy	3 +1	+50%	+$92	﹤0.01%	2162
2022 Q3	$0	Buy	+2	New	+$238	﹤0.01%	2105

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Covestor's DNA Position: Q2 2026 in Review

Covestor held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Covestor first reported a position in DNA in Q3 2022 and has held it in 16 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Covestor held 1 share of Ginkgo Bioworks worth $0 as of Q2 2026.
Covestor left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2549 holding.
Covestor first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 16 quarters since.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.